Kidney Diseases Completed Phase 3 Trials for Darbepoetin alfa (DB00012)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00093015Trial to Reduce Cardiovascular Events With AranespĀ® Therapy (TREAT)Treatment
NCT00096915Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving DialysisTreatment
NCT00112008Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving DialysisTreatment
NCT00111098Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving DialysisTreatment
NCT00116701Treatment for Subjects With Chronic Kidney Disease Receiving HaemodialysisTreatment
NCT00121602Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney DiseaseTreatment
NCT00124098An Evaluation of AranespĀ® in Subjects With Anaemic Chronic Kidney Disease (CKD)Treatment